SR

Steven A. Rosenberg

US US Dept of Health & Human Services: 34 patents #4 of 3,044Top 1%
CH Chiron: 20 patents #14 of 583Top 3%
UM University of Minnesota: 11 patents #65 of 2,951Top 3%
IB Intima Bioscience: 11 patents #2 of 15Top 15%
XD Xdx: 5 patents #6 of 15Top 40%
KP Kite Pharma: 5 patents #4 of 43Top 10%
TB Therion Biologics: 1 patents #9 of 14Top 65%
WM Wilson Wolf Manufacturing: 1 patents #10 of 18Top 60%
YC Yeda Research And Development Co.: 1 patents #619 of 1,403Top 45%
IL Immunocore Limited: 1 patents #31 of 63Top 50%
FS Fina Research, S.A.: 1 patents #35 of 89Top 40%
BH Brigham and Women's Hospital: 1 patents #847 of 1,764Top 50%
The Johns Hopkins University: 1 patents #1,892 of 4,416Top 45%
📍 Bethesda, MD: #1 of 2,269 inventorsTop 1%
🗺 Maryland: #13 of 35,612 inventorsTop 1%
Overall (All Time): #5,353 of 4,157,543Top 1%
160
Patents All Time

Issued Patents All Time

Showing 101–125 of 160 patents

Patent #TitleCo-InventorsDate
7749719 Melanoma antigens and their use in diagnostic and therapeutic methods Yutaka Kawakami 2010-07-06
7745212 Melanoma antigens and their use in diagnostic and therapeutic methods Yutaka Kawakami 2010-06-29
7723111 Activated dual specificity lymphocytes and their methods of use Patrick Hwu, Michael Kershaw 2010-05-25
7691569 Methods and compositions for diagnosing and monitoring transplant rejection Jay Wohlgemuth, Kirk Fry, Robert Woodward, Ngoc Ly, James Prentice +1 more 2010-04-06
7619057 MHC class II restricted T cell epitopes from the cancer antigen, NY ESO-1 Rong Wang, Gang Zeng 2009-11-17
7612044 Melanoma antigens and their use in diagnostic and therapeutic methods Yutaka Kawakami 2009-11-03
7501501 MHC-Class II restricted melanoma antigens and their use in therapeutic methods Suzanne L. Topalian, Paul F. Robbins 2009-03-10
7476535 TRP2 isoform TRP2-6b containing HLA-A2 restricted epitopes Hung T. Khong 2009-01-13
7419957 Peptides of melanoma antigen and their use in diagnostic, prophylactic and therapeutic methods Patrick Hwu, Rejean LaPointe, Maria R. Parkhurst 2008-09-02
7381405 Methods of preparing lymphocytes that express interleukin-2 and their use in the treatment of cancer Ke Liu 2008-06-03
7378277 Methods and compositions for transforming dendritic cells and activating T cells Patrick Hwu, Mark C. Reeves 2008-05-27
RE39788 Gene therapy W. French Anderson, R. Michael Blaese 2007-08-21
7232887 Melanoma antigens and their use in diagnostic and therapeutic methods Yutaka Kawakami 2007-06-19
7094752 Peptide ligands of the urokinase receptor Michael V. Doyle, Harold A. Chapman 2006-08-22
7084239 Cancer peptides of NY-ESO-1/CAG-3 Rong Wang 2006-08-01
7015312 Antibodies to the protein product encoded by ORF3 of the TRP-1 gene and compositions and kits thereof Rong Wang 2006-03-21
7001600 Identification of TRP-2 as a human tumor antigen recognized by cytotoxic T lymphocytes Rong Wang 2006-02-21
6965017 Melanoma antigens and their use in diagnostic and therapeutic methods Yutaka Kawakami 2005-11-15
6951917 MHC-class II restricted melanoma antigens and their use in therapeutic methods Suzane L. Topalian, Paul F. Robbins 2005-10-04
6794358 Peptide ligands of the urokinase receptor Michael V. Doyle, Harold A. Chapman 2004-09-21
6734014 Methods and compositions for transforming dendritic cells and activating T cells Patrick Hwu, Mark C. Reeves 2004-05-11
6537560 Melanoma antigens and their use in diagnostic and therapeutic methods Yutaka Kawakami 2003-03-25
6270778 Melanoma antigens and their use in diagnostic and therapeutic methods Yutaka Kawakami 2001-08-07
6268341 Expression of urokinase plasminogen activator inhibitors Jennifer R. Stratton-Thomas 2001-07-31
6248715 Method of treating a urokinase-type plasminogen activator-mediated disorder Jennifer R. Stratton-Thomas 2001-06-19